Key facts
- This page summarizes O James Sterling's Form 3 filing for Renalytix plc (RNLXY).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jul 2023, 16:24.
O James Sterling - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLXY)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RNLXY
- Reported as of
- 01 Jul 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 Jul 2023, 16:24:44 UTC
- Prior SEC filing
- 13 May 2021
- Next SEC filing
- 07 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Katie Kazem, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
O James Sterling filed Form 3 for Renalytix plc (RNLXY) on 03 Jul 2023.
Change
- Previous filing in this sequence was filed on 13 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RNLX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,805,236
- Date
- 01 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney